Safety and Feasibility of the ELIOS System in POAG Patients

Completed · Not applicable

Conditions studied: Glaucoma, Primary Open Angle

In brief

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)

Key facts

Study ID

NCT05999006

Run by

Elios Vision, Inc.

People needed

22

Starts

2023-10-18

Expected to finish

2026-04-28

Last updated by the study team

2026-06-16

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of mild to moderate POAG
• Medicated IOP of <=24 mmHg
• Shaffer angle grade of III or IV
• CD ratio <=0.8
• At least 45 years old

You may not qualify if…

• Closed-angle and secondary glaucomas
• Prior incisional glaucoma surgery, intraocular surgery, or corneal surgery
• Cannot undergo medication washout in the study eye
• Diagnosis of degenerative visual disorders Non-study eye with BCVA worse than 20/80 Known corticosteroid responder Pregnant or nursing women; or women of childbearing potential not using medically acceptable birth control

Where it is running

• Elios Vision Clinical Site — Glendale, Arizona, United States
• Elios Vision Clinical Site — Rock Island, Illinois, United States
• Elios Vision Clinical Site — St Louis, Missouri, United States
• Elios Vision Clinical Site — Oklahoma City, Oklahoma, United States
• Elios Vision Clinical Site — El Paso, Texas, United States
• Elios Vision Clinical Site — Kenosha, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.